<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68314">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02216526</url>
  </required_header>
  <id_info>
    <org_study_id>CRC-SP-A-15</org_study_id>
    <nct_id>NCT02216526</nct_id>
  </id_info>
  <brief_title>Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents</brief_title>
  <official_title>A Prevalence and Multi-center Randomized Parallel-group Pragmatic Trial to Compare the Effectiveness of Standardized Skin Care Regimens on Skin Health in Nursing Home Residents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PD Dr. Jan Kottner</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Residents of institutional long-term care facilities are at high risk for developing skin
      and tissue diseases, e.g. xerosis cutis (including pruritus), infections (e.g., tinea pedis,
      candidiasis), chronic wounds or neoplastic changes (e.g. actinic keratosis, malignant
      melanoma) but there are few epidemiological figures about the actual frequencies of these
      conditions in nursing homes. Therefore, in the first part of this study we aim at measuring
      key dermatological conditions and associated health and functional status, and the skin care
      practice of aged nursing home residents (&quot;prevalence study&quot;).

      Basic skin care interventions are believed to reduce skin dryness and to enhance skin
      health. Thus, the second aim of this study is to investigate the effectiveness of two
      structured skin care regimens compared to the routine standard skin care on skin health in
      nursing home residents (&quot;intervention study&quot;).

      The study will be conducted in a random sample of seven out of approximately 300
      institutional long term care facilities of the federal state of Berlin.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in Overall Dry Skin Score (ODS)</measure>
    <time_frame>Day 56+/-4</time_frame>
    <description>Clinical assessment of the presence or severity of skin dryness using a five point rating scale at right lower leg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stratum corneum hydration (SCH)</measure>
    <time_frame>Baseline, Day 56 +/- 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transepidermal water loss (TEWL)</measure>
    <time_frame>Baseline, Day 56 +/- 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin surface pH</measure>
    <time_frame>Baseline, Day 56 +/- 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Itch Assessment</measure>
    <time_frame>Baseline, Day 28 +/- 3, Day 56 +/- 4</time_frame>
    <description>Self-completion of the 5-D itch scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure ulcer and skin tears</measure>
    <time_frame>Baseline, Day 28 +/- 3, Day 56 +/- 4</time_frame>
    <description>Clinical assessment of the presence and/or severity of a pressure ulcer and skin tears</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incontinence associated dermatitis (IAD)</measure>
    <time_frame>Baseline, Day 28 +/- 3, Day 56 +/- 4</time_frame>
    <description>Clinical assessment of the presence and/or severity of incontinence associated dermatitis according to the IAD-IT classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Baseline, Day 56 +/- 4</time_frame>
    <description>Self-completion of the WHO-Five Well-being Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Sleep</measure>
    <time_frame>Baseline, Day 56 +/- 4</time_frame>
    <description>Self-completion of the Richards-Campbell Sleep Questionnaire (RCSQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resident and caregiver satisfaction</measure>
    <time_frame>Day 28 +/- 3, Day 56 +/- 4</time_frame>
    <description>Self-completion of a satisfaction questionnaire by the resident and caregiver</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">133</enrollment>
  <condition>Xerosis Cutis</condition>
  <arm_group>
    <arm_group_label>Cetaphil® Restoraderm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cetaphil® Restoraderm Body Wash, once daily for 8 weeks and Cetaphil® Restoraderm Body Moisturizer, twice daily for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Excipial</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Excipial Kids Body Wash, once daily for 8 weeks and Excipial U Lipolotio (4% urea), twice daily for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard skin care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual skin care routine of the nursing home resident</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cetaphil® Restoraderm</intervention_name>
    <arm_group_label>Cetaphil® Restoraderm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Excipial</intervention_name>
    <arm_group_label>Excipial</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        &quot;Prevalence study&quot;

          -  Living in the nursing home at the time of data collection;

          -  Being 65+ years;

          -  Written informed consent (or by legal representative);

        Additional inclusion criteria for the &quot;intervention study&quot;

          -  Overall dry skin score (ODS) of 2 to 4 at the right and left leg;

          -  Willingness and ability to fulfil the study requirements.

        Exclusion Criteria:

        &quot;Prevalence study&quot;

          -  Residents at the end of life (dying persons).

        Additional exclusion criteria for the &quot;intervention study&quot;

          -  Any dermatological condition or skin affection, e.g. acute weeping, excoriated or
             inflammatory dermatitis, or skin treatment which may interfere with the study
             assessments at the discretion of the investigator;

          -  Any unstable acute or chronic pathology or condition that may interfere with the
             study conduct at the discretion of the investigator;

          -  Any use of topical drugs on the investigational areas two weeks prior to inclusion;

          -  Systemic application of corticosteroids, antihistamine or other anti-inflammatory
             drugs;

          -  Known allergy or intolerance to any ingredient of the study products, e.g. urea.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>July 28, 2015</lastchanged_date>
  <firstreceived_date>August 11, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>PD Dr. Jan Kottner</investigator_full_name>
    <investigator_title>Scientific Director Clinical Research Center for Hair and Skin Science</investigator_title>
  </responsible_party>
  <keyword>Skin health</keyword>
  <keyword>Nursing</keyword>
  <keyword>Long-term care</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
